FindTrial
Sign In

Serum profiles of paracetamol and glutathione after high doses of paracetamol for 6 days -

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-000627-17-IS
Enrollment
15
Registered
2007-04-03
Start date
Unknown
Completion date
Unknown
Last updated
2012-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Trade Name: Panodil Pharmaceutical Form: Tablet

Sponsors

University of Iceland
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy, age 18-60 years. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: History of liver or kidney diseases, history of alcohol abuse, chronic drug use, allergy for paracetamol.

Design outcomes

Primary

MeasureTime frame
Secondary Objective: To study the possible changes in the blood concentration of glutathione.;Primary end point(s): Blood concentrations of paracetamol snd glutathione. Pharmacokinetic parameters for paracetamol. ;Main Objective: To describe the pharmacokinetics after large doses for 6 days.—

Countries

Iceland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026